Study comparing Zenagamtide and Semaglutide for weight loss
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new medicine Zenagamtide to see if it helps people with excess weight lose more weight than Semaglutide, an existing weight loss drug. You may join if you are an adult with overweight or obesity but do not have diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have excess body weight (your doctor can confirm)
- You do not have type 1 or type 2 diabetes
- Your blood sugar level (HbA1c) is below 6.5% at the screening test
- You have not taken any GLP-1 medicines (like Ozempic or Wegovy) or similar drugs in the past year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study is testing a new tablet called Zenagamtide to help people with extra body weight lose weight. It's for adults who are not diabetic and haven't used similar weight loss drugs before.
This study tests a new medicine called NNC0487-0111 to see how well it helps people with excess body weight and type 2 diabetes lose weight, compared to another medicine called semaglutide. It may be an option if you have type 2 diabetes and are looking to manage your weight.
This study tests a new medicine called Zenagamtide to help people with excess body weight lose weight. It is designed for adults in Asia who do not have diabetes.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.